| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Stephen R Dager | Q62562418 |
| P2093 | author name string | Stefan Posse | |
| Neva M Corrigan | |||
| Todd L Richards | |||
| P2860 | cites work | Image Formation by Induced Local Interactions: Examples Employing Nuclear Magnetic Resonance | Q22122427 |
| N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system | Q28141091 | ||
| Minicolumnar pathology in autism | Q28200704 | ||
| Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator | Q28236845 | ||
| Neuroglial activation and neuroinflammation in the brain of patients with autism | Q29619689 | ||
| Psychiatry and the new magnetic resonance era. | Q30558957 | ||
| Modeling brain compartmental lactate response to metabolic challenge: a feasibility study | Q30586996 | ||
| Mitochondrial dysfunction in bipolar disorder | Q30640247 | ||
| Magnetic resonance spectroscopy: current and future applications in psychiatric research | Q30673059 | ||
| Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis | Q31001850 | ||
| Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders | Q31023501 | ||
| N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain | Q31034516 | ||
| What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. | Q31036551 | ||
| Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla | Q31117667 | ||
| The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia | Q31864336 | ||
| Toward a developmental neurobiology of autism. | Q33211115 | ||
| Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls | Q33288189 | ||
| NMDA receptor hypofunction model of schizophrenia | Q33813143 | ||
| Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia | Q33944802 | ||
| Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling | Q33971691 | ||
| Pervasive developmental disorders in preschool children: confirmation of high prevalence | Q33987505 | ||
| Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study | Q34066948 | ||
| MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis | Q48333060 | ||
| In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism | Q48345676 | ||
| Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. | Q48436532 | ||
| A clinicopathological study of autism | Q48454065 | ||
| Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders | Q48483195 | ||
| Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic | Q48498036 | ||
| Brain structural abnormalities in young children with autism spectrum disorder | Q48536220 | ||
| In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective | Q48553223 | ||
| Brain pH response to hyperventilation in panic disorder: preliminary evidence for altered acid-base regulation | Q48595000 | ||
| Localized magnetic resonance spectroscopy measurement of brain lactate during intravenous lactate infusion in healthy volunteers | Q48598937 | ||
| Magnetic Resonance in Preterm and Term Newborns: 1H-Spectroscopy in Developing Human Brain | Q48621130 | ||
| Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay | Q48633302 | ||
| Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia | Q48691523 | ||
| In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI). | Q48699346 | ||
| Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study | Q48728107 | ||
| Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex | Q48728126 | ||
| Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study | Q48823084 | ||
| 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis | Q48864019 | ||
| Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production | Q49158163 | ||
| Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals | Q50307306 | ||
| Epilepsy in adolescents and young adults with autistic disorder | Q50313117 | ||
| Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism | Q50313632 | ||
| Biological markers in panic states: lactate-induced panic and mitral valve prolapse. | Q51201439 | ||
| Lactate provocation of panic attacks. I. Clinical and behavioral findings. | Q51231088 | ||
| Genetic factors in anxiety disorders. | Q51239731 | ||
| N-Acetyl-L-aspartic acid in brain. | Q51332544 | ||
| Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. | Q51943076 | ||
| Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. | Q51960889 | ||
| The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. | Q51973405 | ||
| Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. | Q51980100 | ||
| Lactate Metabolism in Anxiety Neurosis | Q52128598 | ||
| Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain | Q68467316 | ||
| Physiological NMR spectroscopy: from isolated cells to man | Q68679549 | ||
| Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects | Q72180851 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy | Q72521745 | ||
| Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy | Q73230855 | ||
| Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study | Q73851100 | ||
| Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis | Q79362737 | ||
| Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. | Q34084795 | ||
| Glutamate transporters in neurologic disease | Q34187611 | ||
| Glial cell abnormalities in major psychiatric disorders: the evidence and implications | Q34384584 | ||
| Human brain metabolic response to caffeine and the effects of tolerance | Q34492781 | ||
| Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T. | Q34522330 | ||
| Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia | Q34529602 | ||
| The developmental neurobiology of autism spectrum disorder. | Q34542748 | ||
| 9.4T human MRI: preliminary results. | Q34577998 | ||
| Real-time metabolic imaging | Q34983950 | ||
| Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression | Q35111592 | ||
| Autism as a disorder of neural information processing: directions for research and targets for therapy | Q35705869 | ||
| Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging | Q35946663 | ||
| Brain imaging: applications in psychiatry | Q36444917 | ||
| Clinical applications of magnetic resonance spectroscopy. | Q36717717 | ||
| Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy | Q36757353 | ||
| Short echo time proton MR spectroscopic imaging. | Q36770461 | ||
| 1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo | Q37680300 | ||
| The genetics of panic disorder and agoraphobia. | Q39395759 | ||
| Brain metabolic alterations in medication-free patients with bipolar disorder | Q40513083 | ||
| Mind glue: implications of glial cell biology for psychiatry | Q40782511 | ||
| Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy | Q40844884 | ||
| Metabolic coupling between glia and neurons. | Q40943523 | ||
| Prefrontal function in schizophrenia: confounds and controversies | Q41242094 | ||
| Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment | Q41381100 | ||
| Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine | Q42478609 | ||
| Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging | Q42602974 | ||
| Gray and white matter brain chemistry in young children with autism | Q42690278 | ||
| Seizure disorders in autism | Q43436169 | ||
| Induced mitochondrial failure in the feline brain: implications for understanding acute post-traumatic metabolic events | Q43678219 | ||
| Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment. | Q43831325 | ||
| In vivo GABA editing using a novel doubly selective multiple quantum filter | Q43900279 | ||
| Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia | Q43901404 | ||
| Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors | Q43941593 | ||
| Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders | Q43977647 | ||
| Glutamate-glutamine cycling in the epileptic human hippocampus | Q44053296 | ||
| Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers | Q44201512 | ||
| Increased cortical GABA concentrations in depressed patients receiving ECT. | Q44336422 | ||
| Coping strategies of panic and control subjects undergoing lactate infusion during magnetic resonance imaging confinement | Q44452373 | ||
| Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia | Q44586215 | ||
| Image formation by induced local interactions. Examples employing nuclear magnetic resonance. 1973. | Q44668402 | ||
| Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. | Q44669007 | ||
| Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder | Q44742906 | ||
| Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla | Q44819132 | ||
| Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES. | Q44880209 | ||
| Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla | Q44880966 | ||
| Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression | Q44966221 | ||
| Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder | Q45035941 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| Regional brain chemical alterations in young children with autism spectrum disorder | Q45832175 | ||
| Elevated serum lactate associated with panic attacks induced by hyperventilation | Q46063507 | ||
| Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T. | Q46114366 | ||
| Slow recovery from voluntary hyperventilation in panic disorder. | Q46197825 | ||
| Carbohydrate metabolism of the rat C6 glioma. An in vivo 13C and in vitro 1H magnetic resonance spectroscopy study | Q46216060 | ||
| Proton spectroscopic imaging of the human brain using phased array detectors. | Q46933839 | ||
| Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla | Q46960149 | ||
| Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years | Q47358712 | ||
| Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain | Q48087241 | ||
| Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. | Q48098762 | ||
| In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy | Q48107457 | ||
| Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients | Q48108349 | ||
| Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists | Q48114938 | ||
| An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects | Q48170660 | ||
| Preliminary application of magnetic resonance spectroscopy to investigate lactate-induced panic | Q48197921 | ||
| Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study | Q48208731 | ||
| Quantitative proton MRS predicts outcome after traumatic brain injury | Q48221233 | ||
| Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy | Q48249893 | ||
| Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain | Q48264889 | ||
| Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy | Q48282047 | ||
| Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study | Q48285951 | ||
| Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia | Q48285976 | ||
| Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity | Q48293694 | ||
| 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients | Q48293704 | ||
| Sensitivity-encoded (SENSE) proton echo-planar spectroscopic imaging (PEPSI) in the human brain | Q48294654 | ||
| Two-dimensional proton echo-planar spectroscopic imaging of brain metabolic changes during lactate-induced panic. | Q48303925 | ||
| P433 | issue | 2 | |
| P921 | main subject | spectroscopy | Q483666 |
| P304 | page(s) | 81-96 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Topics in magnetic resonance imaging : TMRI | Q26841843 |
| P1476 | title | Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders | |
| P478 | volume | 19 |
| Q36589730 | A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder |
| Q47615718 | A novel approach to probing in vivo metabolite relaxation: Linear quantification of spatially modulated magnetization |
| Q26991430 | A review of MR spectroscopy studies of pediatric bipolar disorder |
| Q35569605 | Adults with attention-deficit/hyperactivity disorder - a brain magnetic resonance spectroscopy study |
| Q26798235 | Applications of magnetic resonance imaging for treatment-resistant late-life depression |
| Q37166794 | Autism and Classical Eyeblink Conditioning: Performance Changes of the Conditioned Response Related to Autism Spectrum Disorder Diagnosis |
| Q33530233 | BDNF Val66Met polymorphism and protein levels in amniotic fluid |
| Q36977035 | Behavioral deficits, abnormal corticosterone, and reduced prefrontal metabolites of adolescent rats subject to early life stress |
| Q30880781 | Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study |
| Q33993209 | Biomarkers in development of psychotropic drugs. |
| Q31122964 | Can Neuroimaging Provide Reliable Biomarkers for Obsessive-Compulsive Disorder? A Narrative Review |
| Q60947851 | Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study |
| Q26830626 | Consensus paper: pathological role of the cerebellum in autism |
| Q34095771 | Decreased frontal lobe function in people with Internet addiction disorder |
| Q31168122 | Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis |
| Q36295874 | Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study |
| Q34135715 | GABA-based evaluation of neurologic conditions: MR spectroscopy. |
| Q33759151 | Improving 1H MRSI measurement of cerebral lactate for clinical applications |
| Q30578725 | MR spectroscopic imaging: principles and recent advances |
| Q26865740 | Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies |
| Q37810163 | Metabonomic studies of schizophrenia and psychotropic medications: focus on alterations in CNS energy homeostasis |
| Q37060166 | Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation |
| Q28387732 | Neuroimaging of Parkinson's disease: Expanding views |
| Q30565982 | Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis |
| Q36055870 | Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment. |
| Q45297540 | Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease |
| Q30394990 | Profiling neuronal ion channelopathies with non-invasive brain imaging and dynamic causal models: Case studies of single gene mutations |
| Q50312134 | Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder |
| Q64067792 | Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients |
| Q48058737 | Proton spectroscopy study of the dorsolateral prefrontal cortex in youth with familial depression. |
| Q33875887 | Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here |
| Q33783427 | Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder |
| Q33887666 | Structural neuroimaging of geriatric depression |
Search more.